Chronic Pain Treatment Market Forecast Signals New Revenue Opportunities Through 2030
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Chronic Pain Treatment Market Growth Potential: How Will Market Size Change Through 2030?
The market for chronic pain treatment has demonstrated substantial expansion over the past few years. Its value is projected to rise from $109.05 billion in 2025 to $119.32 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.4%. This historical growth has been driven by several factors, including the utilization of opioids, the prevalence of musculoskeletal disorders, an increasingly aged population, the establishment of hospital-based pain clinics, and the management of pain following surgical procedures.
The chronic pain treatment market is projected to experience significant expansion in the coming years, with a forecasted value of $168.99 billion by 2030, reflecting a compound annual growth rate (CAGR) of 9.1%. This anticipated growth during the forecast period is driven by factors such as opioid regulation, the adoption of device-based therapies, the rising prevalence of chronic diseases, the integration of mental health treatments, and the expansion of outpatient pain care services. Key trends shaping this period include a notable shift towards non-opioid pain management approaches, the increasing use of neuromodulation devices, the broader adoption of multidisciplinary pain management strategies, a stronger emphasis on personalized treatment plans, and the incorporation of psychological support into pain care regimens.
Download A Free Sample Report For Comprehensive Market Insights:
#Chronic Pain Treatment Market Growth Factors: Which Forces Are Supporting Market Expansion?
The increasing occurrence of arthritis pain is anticipated to boost the chronic pain treatment market in the coming period. Arthritis pain involves joint discomfort, ache, or tenderness resulting from inflammation or deterioration linked to arthritis. This rising trend is largely attributed to an aging population, where natural joint wear and tear grows with advancing age, elevating the likelihood of arthritis-related conditions. Chronic pain management assists with arthritis pain by mitigating inflammation and nerve hypersensitivity, thereby alleviating discomfort, improving joint mobility, and enhancing the overall well-being of those enduring persistent arthritis symptoms. As an example, in July 2024, the Centers for Disease Control and Prevention, a US government entity, reported that around 21.2% of adults aged 18 and older in the United States had been diagnosed with arthritis in 2023. Consequently, the growing prevalence of arthritis pain is fueling expansion in the chronic pain treatment market.
Chronic Pain Treatment Market Segment Outlook: Which Categories Are Expanding The Fastest?
The chronic pain treatment market covered in this report is segmented –
1) By Product Type: Drugs, Devices
2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications
3) By Distribution channels: Direct, Indirect
4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users
Subsegments:
1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications
2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices
Chronic Pain Treatment Market Industry Trends: What Changes Are Reshaping Demand?
In the chronic pain treatment market, major players are prioritizing the creation of advanced solutions like closed-loop spinal cord stimulation (SCS) systems to address the growing need for non-opioid alternatives that offer superior long-term pain management and enhanced patient well-being. These closed-loop systems are implantable, rechargeable neurostimulators that continuously detect neural activity and dynamically adjust electrical stimulation in real time, setting them apart from conventional open-loop SCS devices that rely on fixed, unresponsive settings. A notable example is Medtronic plc, an Irish medical device company, which secured U.S. Food and Drug Administration (FDA) approval in April 2024 for its Inceptiv Neurostimulation System. This compact, rechargeable implant utilizes sensing electrodes to monitor evoked neural responses and fine-tune stimulation automatically, offering full-body compatibility with 1.5T and 3T MRI scans through impedance-independent sensing. It is indicated for managing chronic, persistent pain in the trunk or limbs and is engineered to deliver more consistent relief, superior responder outcomes, and greater comfort compared to standard fixed-output SCS systems.
Chronic Pain Treatment Market Key Companies And Competitive Benchmarking
Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.
Access The Complete Chronic Pain Treatment Market Report:
Chronic Pain Treatment Market Regional Outlook: Where Are The Largest Opportunities Located?
North America was the largest region in the chronic pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
